Susan Altschuller - 14 Aug 2024 Form 4 Insider Report for Mural Oncology plc (MURA)

Reporting relationship: Director
Issuer ticker: MURA
Reported as of: 14 Aug 2024
Net transaction value: +$32,071
SEC form: 4
Accepted by SEC: 15 Aug 2024, 16:15:04 UTC
Prior SEC filing: 05 Aug 2024
Next SEC filing: 01 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Maiken Keson-Brookes, attorney-in-fact for Susan Altschuller

Key filing fact

Susan Altschuller filed Form 4 for Mural Oncology plc (MURA) on 15 Aug 2024.

Key facts

This page summarizes Susan Altschuller's Form 4 filing for Mural Oncology plc (MURA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Aug 2024, 16:15.

Change

Previous filing in this sequence was filed on 05 Aug 2024.
Current net transaction value: +$32,071.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MURA transaction

Ordinary Shares

Purchase

Transaction value: $32,071
Shares: +10,000
Change %
Price: $3.21
Shares after: 10,000
Date: 14 Aug 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.17 to $3.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.